Archive for the ‘biological’ tag
Aug 5, 2019
Dr. Wendy Dean, M.D., Senior Vice President of Program Operations, Henry M. Jackson Foundation for the Advancement of Military Medicine — ideaXme — Ira Pastor
Posted by Ira S. Pastor in categories: aging, biotech/medical, DNA, government, health, life extension, military, neuroscience, nuclear weapons, posthumanism
Jun 17, 2018
Harvard Rewinds the Biological Clock of Time
Posted by Nicholi Avery in categories: bioengineering, biological, DNA, health, life extension, science, transhumanism
Investigators at Harvard Medical School have identified the key cellular mechanisms behind vascular aging and its effects on muscle health, and they have successfully reversed the process in animals.
The scientists used a chemical compound that’s an NAD+ booster called NMN which plays a critical role in repairing cellular DNA as well as maintaining cell vitality to test what would happen.
Could reversing the aging of blood vessels hold the key to restoring youthful vitality? If the old adage “you are as old as your arteries” reigns true then the answer is yes, at least in mice.
Continue reading “Harvard Rewinds the Biological Clock of Time” »
Jan 23, 2018
Bioquark Inc. — Staying Alive UK Show — Ira S. Pastor
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, business, disruptive technology, DNA, futurism, genetics, health, neuroscience
Jun 29, 2017
Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, disruptive technology, DNA, genetics, health, life extension, posthumanism, science
Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.
“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”
Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.
Apr 20, 2016
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, biotech/medical, cryonics, disruptive technology, futurism, health, life extension, neuroscience
Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of novel biologics for complex regeneration and disease reversion, and Revita Life Sciences, (http://revitalife.co.in) a biotechnology company focused on translational therapeutic applications of autologous stem cells, have announced that they have received IRB approval for a study focusing on a novel combinatorial approach to clinical intervention in the state of brain death in humans.
This first trial, within the portfolio of Bioquark’s Reanima Project (http://www.reanima.tech) is entitled “Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury” (https://clinicaltrials.gov/ct2/show/NCT02742857?term=bioquark&rank=1), will enroll an initial 20 subjects, and be conducted at Anupam Hospital in Rudrapur, Uttarakhand India.
Oct 27, 2012
Today, a Young Man on Acid Realized that all Matter is Merely Energy Condensed to a…
Posted by Reno J. Tibke in categories: biological, complex systems, cosmology, engineering, existential risks, homo sapiens, human trajectories, humor, information science, particle physics, philosophy, physics
…here’s Tom with the Weather.
That right there is comedian/philosopher Bill Hicks, sadly no longer with us. One imagines he would be pleased and completely unsurprised to learn that serious scientific minds are considering and actually finding support for the theory that our reality could be a kind of simulation. That means, for example, a string of daisy-chained IBM Super-Deep-Blue Gene Quantum Watson computers from 2042 could be running a History of the Universe program, and depending on your solipsistic preferences, either you are or we are the character(s).
It’s been in the news a lot of late, but — no way, right?
Because dude, I’m totally real
Despite being utterly unable to even begin thinking about how to consider what real even means, the everyday average rational person would probably assign this to the sovereign realm of unemployable philosophy majors or under the Whatever, Who Cares? or Oh, That’s Interesting I Gotta Go Now! categories. Okay fine, but on the other side of the intellectual coin, vis-à-vis recent technological advancement, of late it’s actually being seriously considered by serious people using big words they’ve learned at endless college whilst collecting letters after their names and doin’ research and writin’ and gettin’ association memberships and such.
So… why now?
